These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 6684409)
21. Enhanced dispersion of atrial refractoriness as an electrophysiological substrate for vulnerability to atrial fibrillation in patients with paroxysmal atrial fibrillation. Oliveira MM; da Silva N; Timóteo AT; Feliciano J; de Sousa L; Santos S; Marques F; Ferreira R Rev Port Cardiol; 2007; 26(7-8):691-702. PubMed ID: 17939579 [TBL] [Abstract][Full Text] [Related]
22. Myocardial bridging of the left anterior descending coronary artery as a risk factor for atrial fibrillation in patients with hypertrophic obstructive cardiomyopathy: a matched case-control study. Nie C; Zhu C; Yang Q; Xiao M; Meng Y; Wang S BMC Cardiovasc Disord; 2021 Aug; 21(1):382. PubMed ID: 34362314 [TBL] [Abstract][Full Text] [Related]
23. Can common-type atrial flutter be a sign of an arrhythmogenic substrate in paroxysmal atrial fibrillation? Clinical and ablative consequences in patients with coexistent paroxysmal atrial fibrillation/atrial flutter. Moreira W; Timmermans C; Wellens HJ; Mizusawa Y; Philippens S; Perez D; Rodriguez LM Circulation; 2007 Dec; 116(24):2786-92. PubMed ID: 18040030 [TBL] [Abstract][Full Text] [Related]
24. Treatment of atrial fibrillation in hypertrophic cardiomyopathy. Hematpour K; Steinberg JS Anadolu Kardiyol Derg; 2006 Dec; 6 Suppl 2():44-8. PubMed ID: 17162270 [TBL] [Abstract][Full Text] [Related]
25. Epidemiology and classification of atrial fibrillation. Lévy S J Cardiovasc Electrophysiol; 1998 Aug; 9(8 Suppl):S78-82. PubMed ID: 9727680 [TBL] [Abstract][Full Text] [Related]
26. Long-term clinical efficacy and risk of catheter ablation for atrial fibrillation in the elderly. Zado E; Callans DJ; Riley M; Hutchinson M; Garcia F; Bala R; Lin D; Cooper J; Verdino R; Russo AM; Dixit S; Gerstenfeld E; Marchlinski FE J Cardiovasc Electrophysiol; 2008 Jun; 19(6):621-6. PubMed ID: 18462325 [TBL] [Abstract][Full Text] [Related]
27. Consequence of atrial fibrillation and the risk of embolism after percutaneous mitral commissurotomy: the necessity of the maze procedure. Nakajima H; Kobayashi J; Bando K; Yasumura Y; Nakatani S; Kimura K; Niwaya K; Tagusari O; Kitamura S Ann Thorac Surg; 2004 Sep; 78(3):800-5; discussion 805-6. PubMed ID: 15336994 [TBL] [Abstract][Full Text] [Related]
28. Atrial fibrillation, the arrhythmia of the elderly, causes and associated conditions. Levy S Anadolu Kardiyol Derg; 2002 Mar; 2(1):55-60. PubMed ID: 12101796 [TBL] [Abstract][Full Text] [Related]
29. Hypertrophic cardiomyopathy in Tuscany: clinical course and outcome in an unselected regional population. Cecchi F; Olivotto I; Montereggi A; Santoro G; Dolara A; Maron BJ J Am Coll Cardiol; 1995 Nov; 26(6):1529-36. PubMed ID: 7594081 [TBL] [Abstract][Full Text] [Related]
30. [The effects of the ablation of atrial flutter in patients with and without a clinical history of paroxysmal atrial fibrillation]. De Sisti A; Leclercq JF; Fiorello P; Palamara A; Attuel P G Ital Cardiol; 1998 Nov; 28(11):1253-60. PubMed ID: 9866803 [TBL] [Abstract][Full Text] [Related]
31. Effect of transcoronary ablation of septal hypertrophy on clinical outcome in hypertrophic obstructive cardiomyopathy associated with atrial fibrillation. Obergassel L; Lawrenz T; Gietzen FH; Lieder F; Leuner C; Kuhn H; Stellbrink C Clin Res Cardiol; 2006 May; 95(5):254-60. PubMed ID: 16598396 [TBL] [Abstract][Full Text] [Related]
32. [Some special aspects of obstructive cardiomyopathy in patients over 55 years of age (apropos of 14 cases)]. Penther P; Cousteau JP; Gay J; Maurice P; Lenègre J Arch Mal Coeur Vaiss; 1970 Sep; 63(9):1230-46. PubMed ID: 4991257 [No Abstract] [Full Text] [Related]
33. [Hypertrophic obstructive cardiomyopathy in elderly patients. Retrospective study of 23 cases]. Brandt CM; Zaehringer M; Bas G; Desroches P; Drui S; Fincker JL Arch Mal Coeur Vaiss; 1986 Dec; 79(13):1925-31. PubMed ID: 3105505 [TBL] [Abstract][Full Text] [Related]
34. [Thyrotoxicosis in patients hospitalized because for atrial fibrillation]. Qvist P; Vejby-Christensen H Ugeskr Laeger; 1989 Sep; 151(37):2373-4. PubMed ID: 2800005 [TBL] [Abstract][Full Text] [Related]
35. Association Between Thyroid Dysfunction and Incidence of Atrial Fibrillation in Patients With Hypertrophic Obstructive Cardiomyopathy. Meng X; Wang XL; Zhang ZY; Zhang K; Gao J; Zheng JL; Wang JJ; Liu YP; Yang J; Li C; Zheng YT; Shao C; Wang WY; Tang YD Front Endocrinol (Lausanne); 2022; 13():875003. PubMed ID: 35860698 [TBL] [Abstract][Full Text] [Related]
36. Infective endocarditis complicating hypertrophic obstructive cardiomyopathy: an unusual mural pattern. Fyfe B; Ianosi-Irimie M; Motavalli L Cardiovasc Pathol; 2010; 19(1):e5-7. PubMed ID: 19026576 [TBL] [Abstract][Full Text] [Related]
37. Incidence of ischemic strokes in hypertrophic cardiomyopathy is markedly increased if complicated by atrial fibrillation. Higashikawa M; Nakamura Y; Yoshida M; Kinoshita M Jpn Circ J; 1997 Aug; 61(8):673-81. PubMed ID: 9276772 [TBL] [Abstract][Full Text] [Related]
38. Management of Atrial Fibrillation in Hypertrophic Cardiomyopathy. MacIntyre C; Lakdawala NK Circulation; 2016 May; 133(19):1901-5. PubMed ID: 27166348 [No Abstract] [Full Text] [Related]